Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463099
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463099
Gastroparesis Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections); By Disease Class; By End User; By Region; Segment Forecast, 2024- 2032
PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global gastroparesis drugs market size is expected to reach USD 6,662.35 Million by 2032, according to a new study by Polaris Market Research. The report "Gastroparesis Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections); By Disease Class; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The gastroparesis drugs market has been experiencing steady growth globally, driven by several factors contributing to increased demand and market expansion. Gastroparesis, a condition characterized by delayed emptying of the stomach, poses significant challenges for affected individuals, leading to symptoms such as nausea, vomiting, bloating, and abdominal discomfort. As awareness about this condition grows among healthcare professionals and patients alike, the demand for effective treatments continues to rise, propelling the gastroparesis drugs market forward.
One of the primary driving factors behind the growth of the gastroparesis drugs market is the increasing prevalence of gastrointestinal disorders, including gastroparesis. With changing dietary habits, sedentary lifestyles, and rising incidences of diabetes, the incidence of gastroparesis is on the rise globally. This surge in patient numbers has created a substantial market opportunity for pharmaceutical companies to develop and commercialize novel drugs catering to the unmet medical needs of these individuals. Moreover, the aging population, particularly in developed regions, contributes to the growing patient pool, further boosting market growth.
Furthermore, advancements in medical technology and drug development have led to the introduction of innovative treatment options for gastroparesis. Pharmaceutical companies are investing significantly in research and development activities to discover and develop new drugs with improved efficacy and safety profiles. These efforts have resulted in the emergence of novel therapeutic agents, including prokinetic agents, antiemetics, and other drugs targeting specific pathways involved in gastric motility disorders. The availability of a diverse range of treatment options provides healthcare providers with more choices to tailor therapy according to individual patient needs, thereby driving market growth.
Gastroparesis Drugs Market Report Highlights
Prokinetic agents segment accounted for noteworthy share in 2023, that is due to its ability to boost stomach muscles contractions and movement
Diabetic gastroparesis segment held the maximum share in 2023, owing to significant prevalence of diabetes due to change in people lifestyle and consumption patterns
Pharmacies segment will grow at highest pace during forecast period, that is attributed to significant expansion of retail pharmacy chains and easy accessibility to patients
North America dominated the global market in 2023, on account of rising prevalence of diabetes and presence of advanced healthcare infrastructure
The key market players include Medtronic Plc, Rhythm Pharmaceuticals, Vanda Pharmaceuticals, Abbott Laboratories, AbbVie Inc., and Pfizer Inc.
Polaris Market Research has segmented the gastroparesis drugs market report based on drug class, disease class, end user, and region:
Gastroparesis Drugs, Drug Class Outlook (Revenue - USD Million, 2023 - 2032)
- Prokinetic Agents
- Antiemetic Agents
- Botulinum Toxin Injections
Gastroparesis Drugs, Disease Class Outlook (Revenue - USD Million, 2023 - 2032)
- Diabetic Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Others
Gastroparesis Drugs, End User Outlook (Revenue - USD Million, 2023 - 2032)
- Hospitals
- Pharmacies
- Clinics
- E-commerce
Gastroparesis Drugs, Regional Outlook (Revenue - USD Million, 2023 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4776
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Gastroparesis Drugs Market Insights
- 4.1. Gastroparesis Drugs Market - End User Snapshot
- 4.2. Gastroparesis Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence of diabetes and geriatric population to boost market growth
- 4.2.1.2. Regulatory approvals for new drugs for gastroparesis treatment to boost market growth.
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of novel treatment options and regulatory hurdles to restrain growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Gastroparesis Drugs Market End User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Gastroparesis Drugs Market, by Disease Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 5.3. Diabetic Gastroparesis
- 5.3.1. Global Gastroparesis Drugs Market, by Diabetic Gastroparesis, by Region, 2019-2032 (USD Million)
- 5.4. Idiopathic Gastroparesis
- 5.4.1. Global Gastroparesis Drugs Market, by Idiopathic Gastroparesis, by Region, 2019-2032 (USD Million)
- 5.5. Post-surgical Gastroparesis
- 5.5.1. Global Gastroparesis Drugs Market, by Post-surgical Gastroparesis, by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global Gastroparesis Drugs Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Gastroparesis Drugs Market, by Drug Class
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 6.3. Prokinetic Agents
- 6.3.1. Global Gastroparesis Drugs Market, by Prokinetic Agents, by Region, 2019-2032 (USD Million)
- 6.4. Antiemetic Agents
- 6.4.1. Global Gastroparesis Drugs Market, by Antiemetic Agents, by Region, 2019-2032 (USD Million)
- 6.5. Botulinum Toxin Injections
- 6.5.1. Global Gastroparesis Drugs Market, by Botulinum Toxin Injections, by Region, 2019-2032 (USD Million)
7. Global Gastroparesis Drugs Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Gastroparesis Drugs Market, by Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Pharmacies
- 7.4.1. Global Gastroparesis Drugs Market, by Pharmacies, By Region, 2019-2032 (USD Million)
- 7.5. Clinics
- 7.5.1. Global Gastroparesis Drugs Market, by Clinics, By Region, 2019-2032 (USD Million)
- 7.6. E-commerce
- 7.6.1. Global Gastroparesis Drugs Market, by E-commerce, By Region, 2019-2032 (USD Million)
8. Global Gastroparesis Drugs Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Gastroparesis Drugs Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Gastroparesis Drugs Market - North America
- 8.3.1. North America: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.3.2. North America: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.3.3. North America: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.3.4. Gastroparesis Drugs Market - U.S.
- 8.3.4.1. U.S.: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.3.5. Gastroparesis Drugs Market - Canada
- 8.3.5.1. Canada: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4. Gastroparesis Drugs Market - Europe
- 8.4.1. Europe: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.2. Europe.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.3. Europe: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.4. Gastroparesis Drugs Market - UK
- 8.4.4.1. UK: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.4.3. UK: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.5. Gastroparesis Drugs Market - France
- 8.4.5.1. France: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.5.2. France.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.5.3. France: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.6. Gastroparesis Drugs Market - Germany
- 8.4.6.1. Germany: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.7. Gastroparesis Drugs Market - Italy
- 8.4.7.1. Italy: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.8. Gastroparesis Drugs Market - Spain
- 8.4.8.1. Spain: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.9. Gastroparesis Drugs Market - Netherlands
- 8.4.9.1. Netherlands: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.10. Gastroparesis Drugs Market - Russia
- 8.4.10.1. Russia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5. Gastroparesis Drugs Market - Asia Pacific
- 8.5.1. Asia Pacific: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.4. Gastroparesis Drugs Market - China
- 8.5.4.1. China: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.4.2. China.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.4.3. China: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.5. Gastroparesis Drugs Market - India
- 8.5.5.1. India: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.5.2. India.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.5.3. India: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.6. Gastroparesis Drugs Market - Malaysia
- 8.5.6.1. Malaysia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.7. Gastroparesis Drugs Market - Japan
- 8.5.7.1. Japan: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.8. Gastroparesis Drugs Market - Indonesia
- 8.5.8.1. Indonesia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.9. Gastroparesis Drugs Market - South Korea
- 8.5.9.1. South Korea: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.6. Gastroparesis Drugs Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.6.4. Gastroparesis Drugs Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.6.5. Gastroparesis Drugs Market - UAE
- 8.6.5.1. UAE: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.6.6. Gastroparesis Drugs Market - Israel
- 8.6.6.1. Israel: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.6.7. Gastroparesis Drugs Market - South Africa
- 8.6.7.1. South Africa: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.7. Gastroparesis Drugs Market - Latin America
- 8.7.1. Latin America: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.7.4. Gastroparesis Drugs Market - Mexico
- 8.7.4.1. Mexico: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.7.5. Gastroparesis Drugs Market - Brazil
- 8.7.5.1. Brazil: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- 8.7.6. Gastroparesis Drugs Market - Argentina
- 8.7.6.1. Argentina: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott Laboratories (US)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AbbVie Inc. (US)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Allergan Inc. (US)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Evoke Pharma (US)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Medtronic Plc (Ireland)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Neurogastrx Inc. (US)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Pfizer Inc. (US)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Rhythm Pharmaceuticals Inc. (US)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Salix Pharmaceuticals (US)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. TEVA Pharmaceutical (Israel)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Vanda Pharmaceuticals Inc. (US)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Product Code: PM4776
List of Tables
- Table 1 Global Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 2 Global Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 3 Global Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 4 Gastroparesis Drugs Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 5 North America: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 6 North America: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 7 North America: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 8 U.S.: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 9 U.S.: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 10 U.S.: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 11 Canada: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 12 Canada: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 13 Canada: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 14 Europe: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 15 Europe: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 16 Europe: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 17 UK: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 18 UK: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 19 UK: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 20 France: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 21 France: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 22 France: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 23 Germany: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 24 Germany: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 25 Germany: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 26 Italy: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 27 Italy: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 28 Italy: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 29 Spain: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 30 Spain: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 31 Spain: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 32 Netherlands: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 33 Netherlands: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 34 Netherlands: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 35 Russia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 36 Russia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 37 Russia: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 38 Asia Pacific: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 39 Asia Pacific: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 40 Asia Pacific: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 41 China: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 42 China: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 43 China: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 44 India: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 45 India: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 46 India: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 47 Malaysia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 48 Malaysia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 49 Malaysia: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 50 Japan: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 51 Japan: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 52 Japan: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 53 Indonesia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 54 Indonesia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 55 Indonesia: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 56 South Korea: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 57 South Korea: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 58 South Korea: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 59 Middle East & Africa: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 60 Middle East & Africa: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 61 Middle East & Africa: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 62 Saudi Arabia: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 63 Saudi Arabia: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 64 Saudi Arabia: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 65 UAE: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 66 UAE: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 67 UAE: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 68 Israel: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 69 Israel: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 70 Israel: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 71 South Africa: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 72 South Africa: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 73 South Africa: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 74 Latin America: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 75 Latin America: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 76 Latin America: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 77 Mexico: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 78 Mexico: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 79 Mexico: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 80 Brazil: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 81 Brazil: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 82 Brazil: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
- Table 83 Argentina: Gastroparesis Drugs Market, by Disease Class, 2019-2032 (USD Million)
- Table 84 Argentina: Gastroparesis Drugs Market, by Drug Class, 2019-2032 (USD Million)
- Table 85 Argentina: Gastroparesis Drugs Market, by End User, 2019-2032 (USD Million)
List of Figures
- Figure 1. Global Gastroparesis Drugs Market, 2019-2032 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Drug Class
- Figure 7. Global Gastroparesis Drugs Market, by Drug Class, 2022 & 2032 (USD Million)
- Figure 8. Market by Disease Class
- Figure 9. Global Gastroparesis Drugs Market, by Disease Class, 2022 & 2032 (USD Million)
- Figure 10. Market by End User
- Figure 11. Global Gastroparesis Drugs Market, by End User, 2022 & 2032 (USD Million)
- Figure 12. Gastroparesis Drugs Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 13. Strategic Analysis - Gastroparesis Drugs Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.